Apellis Pharmaceuticals (APLS) Q2 2024 Earnings

7MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.32
-1.04
-0.76
-0.48

Details

Expected EPS
-0.477454
Actual EPS
-0.54
Surprise EPS
-0.06
Surprise Percent
+13.1%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of -0.54 per share for Q2 2024.

0 Comments

Share your thoughts